ATE374620T1 - Stimulierung der neutrophilfunktion zur behandlung von entzündlichen darmerkrankungen - Google Patents

Stimulierung der neutrophilfunktion zur behandlung von entzündlichen darmerkrankungen

Info

Publication number
ATE374620T1
ATE374620T1 AT01957497T AT01957497T ATE374620T1 AT E374620 T1 ATE374620 T1 AT E374620T1 AT 01957497 T AT01957497 T AT 01957497T AT 01957497 T AT01957497 T AT 01957497T AT E374620 T1 ATE374620 T1 AT E374620T1
Authority
AT
Austria
Prior art keywords
bowel disease
treat
neutrophil function
stimulating neutrophil
inflammable
Prior art date
Application number
AT01957497T
Other languages
English (en)
Inventor
Brian Dieckgraefe
Joshua Korzenik
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Application granted granted Critical
Publication of ATE374620T1 publication Critical patent/ATE374620T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/202—IL-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2033—IL-5
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Plant Substances (AREA)
AT01957497T 2000-08-11 2001-08-09 Stimulierung der neutrophilfunktion zur behandlung von entzündlichen darmerkrankungen ATE374620T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/637,062 US6500418B1 (en) 1999-02-12 2000-08-11 Stimulating neutrophil function to treat inflammatory bowel disease

Publications (1)

Publication Number Publication Date
ATE374620T1 true ATE374620T1 (de) 2007-10-15

Family

ID=24554379

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01957497T ATE374620T1 (de) 2000-08-11 2001-08-09 Stimulierung der neutrophilfunktion zur behandlung von entzündlichen darmerkrankungen

Country Status (8)

Country Link
US (4) US6500418B1 (de)
EP (1) EP1309339B1 (de)
AT (1) ATE374620T1 (de)
AU (2) AU7923501A (de)
CA (1) CA2419855A1 (de)
DE (1) DE60130775T2 (de)
WO (1) WO2002013866A2 (de)
ZA (1) ZA200301630B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7838539B2 (en) * 1999-07-28 2010-11-23 The Board Of Trustees Of The Leland Stanford Junior University Nicotine receptor agonists in stem cell and progenitor cell recruitment
US20020141970A1 (en) * 2001-03-05 2002-10-03 Pettit Dean K. Stable aqueous solutions of granulocyte macrophage colony-stimulating factor
PT2266558T (pt) * 2001-06-07 2017-07-21 Analgesic Neuropharmaceuticals Llc Tratamento da dor neuropática com o antagonista dos recetores de n-metil-d-aspartato (nmda) dextrometorfano
US7129049B2 (en) * 2003-12-22 2006-10-31 Regents Of The University Of Minnesota Method of detecting equine glycogen storage disease IV
WO2008085963A1 (en) * 2007-01-05 2008-07-17 University Of Florida Research Foundation, Inc. Materials and methods for the detection, prevention and treatment of autoimmune disease
BRPI0917130A2 (pt) * 2008-08-25 2015-12-01 Centocor Ortho Biotech Inc biomarcadores para tratamento anti-tnf de colite ulcerativa e transtornos relacionados
EP3171887A1 (de) * 2014-07-24 2017-05-31 Reponex Pharmaceuticals APS Zusammensetzungen mit faktor zur stimulierung von granulozyt-makrophagen-kolonien zur behandlung von entzündlicher darmerkrankung
WO2019246312A1 (en) 2018-06-20 2019-12-26 Progenity, Inc. Treatment of a disease of the gastrointestinal tract with an immunomodulator

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4961926A (en) 1987-11-19 1990-10-09 Sloan-Kettering Institute For Cancer Research Methods for prevention and treatment of mucositis with granulocyte colony stimulating factor
AU641949B2 (en) 1989-10-10 1993-10-07 Amgen, Inc. Compositions and methods for treating or preventing infections in canine and feline animals
IL96477A0 (en) 1989-12-01 1991-08-16 Amgen Inc Megakaryocyte production
CA2082951C (en) 1991-03-15 1999-12-21 Robert M. Platz Pulmonary administration of granulocyte colony stimulating factor
US5581476A (en) 1993-01-28 1996-12-03 Amgen Inc. Computer-based methods and articles of manufacture for preparing G-CSF analogs
US5654186A (en) 1993-02-26 1997-08-05 The Picower Institute For Medical Research Blood-borne mesenchymal cells
JP3441763B2 (ja) 1993-06-30 2003-09-02 キリン−アムジエン・インコーポレーテツド モノクローナル抗体及び該モノクローナル抗体を用いたヒトｇ−ｃｓｆの測定法
WO1995009622A1 (en) 1993-10-06 1995-04-13 Peptide Technology Limited Polyunsaturated fatty acids and uses thereof
US6288030B1 (en) 1993-12-22 2001-09-11 Amgen Inc. Stem cell factor formulations and methods
US6037324A (en) 1996-01-04 2000-03-14 Leukosite, Inc. Inhibitors of MAdCAM-1-mediated interactions and methods of use therefor
US5814308A (en) 1996-03-26 1998-09-29 Zhang; Ke Methods for the treatment of gastrointestinal tract disorders
DE19835080A1 (de) * 1998-07-27 2000-02-03 Doecke Wolf Dietrich Mittel zur Behandlung des Krankheitsbildes Morbus Crohn
WO2000047195A1 (en) * 1999-02-12 2000-08-17 Washington University Stimulating neutrophil function to treat inflammatory bowel disease
DK1175511T3 (da) * 1999-04-13 2006-01-09 Agres Ltd Fremgangsmåde og testsæt til opsamling og opbevaring af biologiske pröver

Also Published As

Publication number Publication date
US7060262B2 (en) 2006-06-13
US6500418B1 (en) 2002-12-31
DE60130775D1 (de) 2007-11-15
AU2001279235B2 (en) 2006-07-13
US7407931B2 (en) 2008-08-05
WO2002013866A9 (en) 2003-08-14
WO2002013866A2 (en) 2002-02-21
WO2002013866A3 (en) 2003-03-13
CA2419855A1 (en) 2002-02-21
US20030035801A1 (en) 2003-02-20
EP1309339B1 (de) 2007-10-03
AU7923501A (en) 2002-02-25
DE60130775T2 (de) 2008-07-17
ZA200301630B (en) 2005-06-09
US20060177419A1 (en) 2006-08-10
US20050169884A1 (en) 2005-08-04
EP1309339A2 (de) 2003-05-14
US7641894B2 (en) 2010-01-05

Similar Documents

Publication Publication Date Title
Goldszmid et al. Host immune response to infection and cancer: unexpected commonalities
LTC1131065I2 (lt) Dialkilfumaratai, skirti autoimuninėms ligoms gydyti
TR200103233T2 (tr) Antikolinerjik etkili bileşik ve ß-mimetikler bazında yeni ilaç bileşimleri.
ATE466085T1 (de) Protease-resistente modifizierte interferon alpha polypeptide
DE69929232D1 (de) Virusähnliche partikel zur induktion von autoantikörpern
HK1096392A1 (en) Substituted heterocycles
DE69826695D1 (de) Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
AR023400A1 (es) Metodos para inducir la muerte de celulas cancerosas y la regresion de tumores
IL181629A0 (en) Compositions and methods for the diagnosis and tretment of tumor
BR9709015A (pt) Quinolina carboxamidas como inbidores de tnf e como inbidores de pde-iv
ES2192839T3 (es) Timosina beta 4 oxidada.
MX2007004025A (es) Uso de derivados del acido nordihidroguaiaretico en el tratamiento de cancer e infecciones microbial y viral resistente a farmacos._.
BR0010702A (pt) Novas quinonas como terapias de doenças
EA200600921A1 (ru) Способы и композиции с применением талидомида для лечения и менеджмента рака и других заболеваний
ATE374620T1 (de) Stimulierung der neutrophilfunktion zur behandlung von entzündlichen darmerkrankungen
NO20051040L (no) Anvendelse av alkylfosfokoliner i kombinasjon med antitumormedikamenter
ATE344670T1 (de) Synergistische kombination zur behandlung von kolorektalkarzinom
SI1546182T1 (sl) Sestavki in postopki za diagnozo in zdravljenje tumorja
DE69934096D1 (de) Zusammensetzungen und methoden zur wundheilung
WO1999024077A3 (en) Compositions and methods for targeted delivery of biologically-active factors
DE60043216D1 (de) Gm-csf zur behandlung von morbus crohn
ATE431742T1 (de) Modifizierte zytokine für krebs therapie
AU2003260452A8 (en) Use of granzyme b as an hsp70/hsp70 peptide dependent inducer of apoptosis in tumor cells
ATE394117T1 (de) Verwendung von cc-chemokine ccl5/rantes mutanten zur behandlung von lebererkrankungen
ATE210990T1 (de) Therapeutischer viraler wirkstoff, welcher das fortschreiten von tumoren stoppt

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties